Receptors, Interleukin-17
"Receptors, Interleukin-17" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface receptors for INTERLEUKIN-17. Several subtypes of receptors have been found, each with its own in specificity for interleukin-17 subtype.
| Descriptor ID |
D053722
|
| MeSH Number(s) |
D12.776.543.750.705.852.420.820
|
| Concept/Terms |
Receptors, Interleukin-17- Receptors, Interleukin-17
- Receptors, Interleukin 17
- IL-17 Receptors
- IL 17 Receptors
- Receptors, IL-17
- Interleukin-17 Receptors
- Interleukin 17 Receptors
Interleukin-17 Receptor A- Interleukin-17 Receptor A
- Interleukin 17 Receptor A
- CDw217 Antigen
- Antigen, CDw217
- Antigens, CDw217
- Interleukin-17 Receptor
- Interleukin 17 Receptor
- Receptor, Interleukin-17
- Cdw217 Antigens
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-17".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-17".
This graph shows the total number of publications written about "Receptors, Interleukin-17" by people in this website by year, and whether "Receptors, Interleukin-17" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Interleukin-17" by people in Profiles.
-
Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor-Positive Breast Cancer. JAMA Oncol. 2024 Oct 01; 10(10):1379-1389.
-
Pancreatic Epithelial IL17/IL17RA Signaling Drives B7-H4 Expression to Promote Tumorigenesis. Cancer Immunol Res. 2024 Sep 03; 12(9):1170-1183.
-
Gut epithelial Interleukin-17 receptor A signaling can modulate distant tumors growth through microbial regulation. Cancer Cell. 2024 01 08; 42(1):85-100.e6.
-
ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism. Sci Transl Med. 2019 03 13; 11(483).
-
Anti-IL17 therapies for psoriasis. Expert Opin Biol Ther. 2019 01; 19(1):45-54.
-
Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells. Cell Host Microbe. 2018 Feb 14; 23(2):203-214.e5.
-
A Review of Brodalumab, an IL-17 Receptor Antagonist, for Moderate-to-Severe Plaque Psoriasis. Skin Therapy Lett. 2017 Jan; 22(1):1-6.
-
Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia. Cancer Cell. 2014 May 12; 25(5):621-37.
-
Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E. Immunity. 2011 Oct 28; 35(4):611-21.
-
An immunoprotective privilege of corneal epithelial stem cells against Th17 inflammatory stress by producing glial cell-derived neurotrophic factor. Stem Cells. 2010 Dec; 28(12):2172-81.